Published: 15 January 2026
About Medsafe
Policy Statements – Archive
This section contains links to historical policy statements issued by Medsafe. Please note that the information contained in these statements may have been superseded. For further information, see:
- current policy statements
- the current guidelines on the regulation of therapeutic products in New Zealand
| Date | Policy |
|---|---|
| 21 June 2017 | Changes to Label Statement Database for OTC loratadine and desloratadine medicines |
| 18 April 2017 | Tips for Changing to the New Data Sheet Format |
| 19 October 2016 | Reminder to sponsors: Timeframes for Provisional Consent |
| 20 July 2015 | Changes to Priority Assessment Process |
| 28 May 2014 | Changes to the Definition of Medicines and Medical Devices Effective 1 July 2014 |
| 2 May 2014 | Biosimilars |
| 10 July 2013 | Subdividing of Tablets |
| 6 May 2013 | Proprietary Ingredients |
| 1 February 2013 | Update to Therapeutic Product Database Reports |
| February 2013 | Changing Registration Situation |
| January 2012 | Acceptability of Claims for Pain Relief |
| 17 May 2011 | Introducing an Abbreviated Approval Process for Eligible Clinical Trials |
| 1 March 2010 | Priority and Abbreviated Assessments Policy |
